<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>17020674</identifier>
<setSpec>1578-8989</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Fernández-Mondéjar, Enrique</dc:author>
<dc:author>Alberca, Ignacio</dc:author>
<dc:author>Carpio, Nelly</dc:author>
<dc:author>Bóveda, José L</dc:author>
<dc:author>Forteza, Alejandro</dc:author>
<dc:author>Llau, Juan V</dc:author>
<dc:author>Torrabadella, Pablo</dc:author>
<dc:author>Gomar, Carmen</dc:author>
<dc:author>García de Lorenzo, Abelardo</dc:author>
<dc:author>Muñoz, Manuel</dc:author>
<dc:author>García-Erce, José A</dc:author>
<dc:author>Páramo, José A</dc:author>
<dc:author>Contreras, Enric</dc:author>
<dc:author>Moral, Victoria</dc:author>
<dc:author>Asuero, Ma Soledad</dc:author>
<dc:author>Gómez, Aurelio</dc:author>
<dc:author>López-Fernández, María F</dc:author>
<dc:author>Quintana, Manuel</dc:author>
<dc:author>Sánchez, Calixto</dc:author>
<dc:description xml:lang="en">The Consensus Document on Alternatives to Allogenic Blood Transfusion (AABT) has been drawn up by a panel of experts from 5 scientific societies. The Spanish Societies of Anesthesiology (SEDAR), Critical Care Medicine and Coronary Units (SEMICYUC), Hematology and Hemotherapy (AEHH), Blood Transfusion (SETS) and Thrombosis and Hemostasis (SETH) have sponsored and participated in this Consensus Document. Alternatives to blood transfusion have been divided into pharmacological and non-pharmacological, with 4 modules and 12 topics. The main objective variable was the reduction of allogenic blood transfusions and/or the number of transfused patients. The extent to which this objective was achieved by each AABT was evaluated using the Delphi method, which classifies the grade of recommendation from A (supported by controlled studies) to E (non-controlled studies and expert opinion). The experts concluded that most of the indications for AABT were based on middle or low grades of recommendation, "C", "D", or "E", thus indicating the need for further controlled studies.</dc:description>
<dc:type>Consensus Development Conference</dc:type>
<dc:language>es</dc:language>
<dc:date>2006 Jul 18 </dc:date>
<dc:title xml:lang="es">Documento «Sevilla» de Consenso sobre Alternativas a la Transfusión de Sangre Alogénica.</dc:title>
<dc:title xml:lang="en">[The "Seville" Consensus Document on Alternatives to Allogenic Blood Transfusion. Sociedades españolas de Anestesiología (SEDAR), Medicina Intensiva (SEMICYUC), Hematología y Hemoterapia (AEHH), Transfusión sanguínea (SETS) Trombosis y Hemostasia (SETH)].</dc:title>
<dc:publisher>Medicina clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
